ITCC-083 Ponatinib
An Open-Label, Single-Arm, Phase 1/2 Study Evaluating the Safety and Efficacy of Single- Agent Ponatinib for the Treatment of advanced Leukemias or Solid Tumors in Pediatric Participants
Promotor Name : Incyte
Investigator Name : M. ZWAAN
Trial registered on clinicaltrial.gov : NCT03934372